Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Aug 8;6(5):e599.
doi: 10.1212/NXI.0000000000000599. eCollection 2019 Sep.

Blood neurofilament light chain at the doorstep of clinical application

Affiliations
Editorial

Blood neurofilament light chain at the doorstep of clinical application

David Leppert et al. Neurol Neuroimmunol Neuroinflamm. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure. Concept for use of serum/plasma NfL for individual therapeutic decision making in MS
DMT = disease-modifying therapy; NfL = neurofilament light chain.

Comment on

References

    1. Thebault S, Tessier D, Lee H, et al. . High serum neurofilament light chain normalises after haematopoietic stem cell transplant for MS. Neurol Neuroimmunol Neuroinflamm 2019;6:e598. doi: 10.1212/NXI.0000000000000598. - DOI - PMC - PubMed
    1. Barro C, Benkert P, Grobke S, et al. . Serum neurofilament light chain correlates with disease activity and predicts clinical and MRI outcomes in MS. Mult Scler J 2017;23:297–298.
    1. Berger T, Stuve O. Neurofilament light chain: an important step toward a disease biomarker in multiple sclerosis. Neurology 2019;92:451–452. - PubMed
    1. Disanto G, Barro C, Benkert P, et al. . Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol 2017;81:857–870. - PMC - PubMed
    1. Khalil M, Teunissen CE, Otto M, et al. . Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 2018;14:577–589. - PubMed

MeSH terms